Isoxanthohumol

CAS No. 70872-29-6

Isoxanthohumol ( Isoxanthohumol )

Catalog No. M19026 CAS No. 70872-29-6

Isoxanthohumol shows an antiviral activity towards herpes viruses (HSV1 and HSV2) and bovine viral diarrhea virus (BVDV).

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 88 In Stock
25MG 176 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Isoxanthohumol
  • Note
    Research use only, not for human use.
  • Brief Description
    Isoxanthohumol shows an antiviral activity towards herpes viruses (HSV1 and HSV2) and bovine viral diarrhea virus (BVDV).
  • Description
    Isoxanthohumol is a less potent derivative of xanthohumol found in Humulus lupulus. It modulates signalling between endothelial cells and vascular smooth muscle cells, induces apoptosis in mature adipocytes, and inhibits differentiation of preadipocytes.
  • Synonyms
    Isoxanthohumol
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HSV-1;HSV-2;BVDV
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    70872-29-6
  • Formula Weight
    354.4
  • Molecular Formula
    C21H22O5
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    CC(=CCC1=C(C=C(C2=C1OC(CC2=O)C3=CC=C(C=C3)O)OC)O)C
  • Chemical Name
    (S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-en-1-yl)chroman-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Atazanavir

    A highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture.

  • BMS-818251

    BMS-818251 (BMS818251) is a novel potent, small-molecule inhibitor of HIV-1 entry with EC50 of 0.019 nM against e laboratory-adapted HIV-1 strain NL4-3.

  • BI 224436

    BI 224436 is a potent, specific, noncatalytic site integrase inhibitor (NCINI) of HIV-1 with EC50 of 11-27 nM against different HIV-1 laboratory strains.